Glucocorticoid-induced loss of DNA methylation in non-neuronal cells and potential involvement of DNMT1 in epigenetic regulation of Fkbp5

Biochemical and Biophysical Research Communications

Volumn 420, Issue 3, 2012, Pages 570-575

  Yang, Xiaoju ^a   Ewald, Erin R ^a   Huo, Yuqing ^a   Tamashiro, Kellie L ^a   Salvatori, Roberto ^a   Sawa, Akira ^a   Wand, Gary S ^a   Lee, Richard S ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

AtT 20; DNA methylation; Dnmt1; Epigenetics; Fkbp5; Hippocampus; HPA axis; Pituitary

Indexed keywords

DEXAMETHASONE; DNA METHYLTRANSFERASE 1; FK 506 BINDING PROTEIN; FK 506 BINDING PROTEIN 5; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL DIVISION; DENTATE GYRUS; DNA METHYLATION; DOSE RESPONSE; EPIGENETICS; HIPPOCAMPUS; HYPOTHALAMUS HYPOPHYSIS SYSTEM; MALE; MOUSE; NERVE CELL PLASTICITY; NERVOUS SYSTEM DEVELOPMENT; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; STRESS;

ANIMALS; CELL LINE, TUMOR; CPG ISLANDS; DENTATE GYRUS; DEXAMETHASONE; DNA (CYTOSINE-5-)-METHYLTRANSFERASE; DNA METHYLATION; ENHANCER ELEMENTS, GENETIC; EPIGENESIS, GENETIC; GLUCOCORTICOIDS; HUMANS; MALE; MICE; MICE, INBRED C57BL; TACROLIMUS BINDING PROTEINS;

EID: 84859582204     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2012.03.035     Document Type: Article

References (34)

1. Cohen S.I. Cushing's syndrome: a psychiatric study of 29 patients. Br. J. Psychiatry 1980, 136:120-124.
2. Dorn L.D., Burgess E.S., Friedman T.C., et al. The longitudinal course of psychopathology in Cushing's syndrome after correction of hypercortisolism. J. Clin. Endocrinol. Metab. 1997, 82:912-919.
3. Flitsch J., Spitzner S., Ludecke D.K. Emotional disorders in patients with different types of pituitary adenomas and factors affecting the diagnostic process. Exp. Clin. Endocrinol. Diabetes 2000, 108:480-485.
4. Starkman M.N., Schteingart D.E., Schork M.A. Cushing's syndrome after treatment: changes in cortisol ACTH levels and amelioration of the depressive syndrome. Psychiatry Res. 1986, 19:177-188.
5. Rubin R.T., Phillips J.J., McCracken J.T., et al. Adrenal gland volume in major depression: relationship to basal and stimulated pituitary-adrenal cortical axis function. Biol. Psychiatry 1996, 40:89-97.
6. Wochnik G.M., Ruegg J., Abel G.A., et al. FK506-binding proteins 51 and 52 differentially regulate dynein interaction and nuclear translocation of the glucocorticoid receptor in mammalian cells. J. Biol. Chem. 2005, 280:4609-4616.
7. Paakinaho V., Makkonen H., Jaaskelainen T., et al. Glucocorticoid receptor activates poised FKBP51 locus through long-distance interactions. Mol. Endocrinol. 2010, 24:511-525.
8. Chao H.M., Ma L.Y., McEwen B.S., et al. Regulation of glucocorticoid receptor and mineralocorticoid receptor messenger ribonucleic acids by selective agonists in the rat hippocampus. Endocrinology 1998, 139:1810-1814.
9. Makino S., Smith M.A., Gold P.W. Increased expression of corticotropin-releasing hormone and vasopressin messenger ribonucleic acid (mRNA) in the hypothalamic paraventricular nucleus during repeated stress: association with reduction in glucocorticoid receptor mRNA levels. Endocrinology 1995, 136:3299-3309.
10. Scammell J.G., Denny W.B., Valentine D.L., et al. Overexpression of the FK506-binding immunophilin FKBP51 is the common cause of glucocorticoid resistance in three New World primates. Gen. Comp. Endocrinol. 2001, 124:152-165.
11. Denny W.B., Valentine D.L., Reynolds P.D., et al. Squirrel monkey immunophilin FKBP51 is a potent inhibitor of glucocorticoid receptor binding. Endocrinology 2000, 141:4107-4113.
12. Binder E.B., Salyakina D., Lichtner P., et al. Polymorphisms in FKBP5 are associated with increased recurrence of depressive episodes and rapid response to antidepressant treatment. Nat. Genet. 2004, 36:1319-1325.
13. Horstmann S., Lucae S., Menke A., et al. Polymorphisms in GRIK4, HTR2A, and FKBP5 show interactive effects in predicting remission to antidepressant treatment. Neuropsychopharmacology 2010, 35:727-740.
14. Zobel A., Schuhmacher A., Jessen F., et al. DNA sequence variants of the FKBP5 gene are associated with unipolar depression. Int. J. Neuropsychopharmacol. 2010, 13:649-660.
15. Binder E.B., Bradley R.G., Liu W., et al. Association of FKBP5 polymorphisms and childhood abuse with risk of posttraumatic stress disorder symptoms in adults. JAMA 2008, 299:1291-1305.
16. Koenen K.C., Uddin M. FKBP5 polymorphisms modify the effects of childhood trauma. Neuropsychopharmacology 2010, 35:1623-1624.
17. Roy A., Gorodetsky E., Yuan Q., et al. Interaction of FKBP5, a stress-related gene, with childhood trauma increases the risk for attempting suicide. Neuropsychopharmacology 2010, 35:1674-1683.
18. Xie P., Kranzler H.R., Poling J., et al. Interaction of FKBP5 with childhood adversity on risk for post-traumatic stress disorder. Neuropsychopharmacology 2010, 35:1684-1692.
19. Appel K., Schwahn C., Mahler J., et al. Moderation of adult depression by a polymorphism in the FKBP5 gene and childhood physical abuse in the general population. Neuropsychopharmacology 2011, 36:1982-1991.
20. Lee R.S., Tamashiro K.L., Yang X., et al. Chronic corticosterone exposure increases expression and decreases deoxyribonucleic acid methylation of Fkbp5 in mice. Endocrinology 2010, 151:4332-4343.
21. Lee R.S., Tamashiro K.L., Yang X., et al. A measure of glucocorticoid load provided by DNA methylation of Fkbp5 in mice. Psychopharmacology (Berl.) 2011, 218:303-312.
22. Harrison R.W., Yeakley J. Corticosterone binding in AtT-20 pituitary tumor cell cytosol: evidence for one class of binding site for both natural and synthetic glucocorticoids. Biochim. Biophys. Acta 1979, 583:360-369.
23. Drouin J., Trifiro M.A., Plante R.K., et al. Glucocorticoid receptor binding to a specific DNA sequence is required for hormone-dependent repression of pro-opiomelanocortin gene transcription. Mol. Cell. Biol. 1989, 9:5305-5314.
24. Paxinos G., Franklin K.B.J. The mouse brain in stereotaxic coordinates 2001, Academic Press, San Diego. second ed.
25. Yang X., Wang S., Rice K.C., et al. Restraint stress and ethanol consumption in two mouse strains. Alcohol Clin. Exp. Res. 2008, 32:840-852.
26. Colella S., Shen L., Baggerly K.A., et al. Sensitive and quantitative universal pyrosequencing methylation analysis of CpG sites. Biotechniques 2003, 35:146-150.
27. Magee J.A., Chang L.W., Stormo G.D., et al. Direct, androgen receptor-mediated regulation of the FKBP5 gene via a distal enhancer element. Endocrinology 2006, 147:590-598.
28. van Praag H., Schinder A.F., Christie B.R., et al. Functional neurogenesis in the adult hippocampus. Nature 2002, 415:1030-1034.
29. Santarelli L., Saxe M., Gross C., et al. Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants. Science 2003, 301:805-809.
30. Snyder J.S., Soumier A., Brewer M., et al. Adult hippocampal neurogenesis buffers stress responses and depressive behaviour. Nature 2011, 476:458-461.
31. Iwamoto K., Bundo M., Ueda J., et al. Neurons show distinctive DNA methylation profile and higher interindividual variations compared with non-neurons. Genome Res. 2011, 21:688-696.
32. Williams K., Christensen J., Pedersen M.T., et al. TET1 and hydroxymethylcytosine in transcription and DNA methylation fidelity. Nature 2011, 473:343-348.
33. Guo J.U., Su Y., Zhong C., et al. Hydroxylation of 5-methylcytosine by TET1 promotes active DNA demethylation in the adult brain. Cell 2011, 145:423-434.
34. Kim M.S., Kondo T., Takada I., et al. DNA demethylation in hormone-induced transcriptional derepression. Nature 2009, 461:1007-1012.